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Zika Virus Is a Public Health Emergency that Poses 
Significant Risks to Pregnant Women
 Zika is the latest in a series of unpredicted & 
unpredictable health threats
– We learn more every day
– Serious problem requiring urgent action
 Most serious risk is to developing fetus 
– For first time in >50 years, a virus has been 
linked to microcephaly, other serious birth 
defects, and poor pregnancy outcomes
– Also associated w/ Guillain-Barré syndrome 
Zika Emergency Funding Request
 Administration asked 
Congress for $1.9 billion 
in emergency funding to 
prepare for, respond to, 
and protect people from 
Zika 
 CDC is part of a robust 
response involving many 
US government agencies 




Zika Virus: Transmission Routes 
 Zika virus infection only recently 
detected in the Americas 
– Same mosquitoes that spread 
dengue and chikungunya
 Three patterns of spread






We Have Learned and Done Much but Need to Learn 
and Do Even More
Some key things we’ve learned
 Mounting evidence of link w/ 
Guillain-Barré & microcephaly
– Neurotropic virus
 Range of adverse pregnancy 
outcomes
 Sexual transmission more 
common than expected
 Pregnant women urgently want 
to take action to protect 
themselves against Zika
 There is much more to be 
learned and done
A few of the key things we’re doing
 Travel and testing guidance
 Guidelines for pregnant women, babies 
and children w/ possible Zika infection and 
for couples interested in conceiving
 Clinical guidelines to prevent sexual 
transmission
 Laboratory tests to states and international 
partners (MAC-ELISA and Trioplex rRT-PCR)
 Studying how long Zika virus stays in 
semen, urine & breast-milk
 Vector control, support to pregnant 
women, and safe blood in Puerto Rico
Key Issues
 Surveillance – human and 
mosquito including 
diagnostics
 Travel/sexual transmission 
advice
 Case response, including 
vector control around cases
 Risk-based guidance – 4 
phases
– Planning
– Start of mosquito season
– First case of local Zika
– Active transmission
Considerations for Zika Action Planning
 Key priority – decrease risk to 
pregnant women and women 
of reproductive age
 Human-based surveillance for 
Zika and surveillance of birth 
defects crucial for response
 Control of Aedes aegypti is 
challenging
 Sustainable mosquito control 
is key
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WHO IS AT RISK?
Denise Jamieson, MD, MPH
Medical Officer
Division of Reproductive Health
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CASE COUNTS AND OUTCOMES OF ZIKA VIRUS
US States*
 312 travel-associated cases†
 0 locally transmitted cases‡
 27 pregnant women
 1 case of Guillain-Barre syndrome
 6 sexually transmitted cases
US Territories
 3 travel-associated cases†
 349 locally transmitted cases‡
 37 pregnant women
 1 case of Guillain-Barre syndrome
 0 sexually transmitted cases
as of March 30, 2016
*40 states and District of Columbia
†Includes cases in travelers and their contacts with presumed sexual or in utero transmission
‡Presumed local mosquito-borne transmission`
ZIKA VIRUS INFECTION IN PREGNANT WOMEN
 Pregnant women can be infected
– Through a mosquito bite
– Through sex with an infected male 
partner
 If infected around conception,
– Zika might present risk to fetus
 If infected during pregnancy,
– Zika can be passed to the fetus 
during pregnancy or around the 
time of birth
ZIKA AND PREGNANCY
 Infection can occur in any trimester
 Limited information about effects of Zika virus 
infection during pregnancy
 Linked to early pregnancy loss and other health 
outcomes
 Previous Zika virus infection 
– Unlikely to affect future pregnancies
– Likely protects against future infection
LINK BETWEEN ZIKA AND MICROCEPHALY
 Mounting evidence supports link
– Temporal association of 
microcephaly occurring after 
widespread Zika 
– High rates of microcephaly in same 
geographic regions as  high rates of 
Zika
Brazil Ministry of Health. Protocol for surveillance and response to the occurrence of microcephaly related to Zika virus infection. 2015  [cited 2016 Feb 2]; Available 
from: 
http://portalsaude.saude.gov.br/images/pdf/2015/dezembro/09/Microcefalia---Protocolo-de-vigil--ncia-e-resposta---vers--o-1----09dez2015-8h.pdf.
CDC LAB CONFIRMS ZIKA IN FETAL TISSUES
 Zika virus RNA and/or 





– Products of conception
MANY QUESTIONS REMAIN
 How often are fetuses infected by Zika virus?
 What proportion of fetuses with Zika virus have birth defects?
 What is the full range of poor outcomes associated with Zika?
WHAT PREGNANT WOMEN CAN DO
 Follow CDC’s travel guidance 
 Do not travel to areas with Zika 
http://wwwnc.cdc.gov/travel/page/zika-information  
WHAT PREGNANT WOMEN CAN DO
WHAT CDC IS DOING TO LEARN MORE
 Established U.S. Zika Pregnancy Registry
 Established Zika Active Pregnancy Surveillance System (Puerto Rico)
 Collaborating with Colombia to monitor pregnancy outcomes in women 
with Zika virus disease
 Collaborating with Brazil to study the link with microcephaly
 Studying how long the virus stays in semen, urine,
and breastmilk
WHAT CDC IS DOING TO KEEP YOU INFORMED
 Providing updated clinical guidelines 
 Sharing up-to-date information 
 Responding to your inquiries (24/7 hotline)
HOW CDC IS SUPPORTING YOUR JURISDICTION
 Building state capacity to identify 
babies with birth defects
 Working with partners to ensure 
that families are linked with services
WHAT YOUR ORGANIZATION CAN DO
 Ensure healthcare providers are aware of resources and updated 
clinical guidance
 Facilitate coordination among your state programs
 Practice effective risk communication principles
 Ensure access to contraception to prevent unintended pregnancy
 Review resources to ensure capacity for children with special 
healthcare needs
 Support the US Zika Pregnancy Registry
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HOW TO IDENTIFY AND DIAGNOSE CASES
Beth Bell, MD, MPH
Director
National Center for Emerging and Zoonotic Infectious Diseases
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IDENTIFYING PEOPLE WITH ZIKA VIRUS INFECTION IS
CHALLENGING
 Most people with Zika do not have symptoms 
or have mild clinical illness that does not 
require medical care







Armstrong and Hennessey. MMWR. 3/18/2016
COMPLICATIONS OF ZIKA VIRUS INFECTION
 There is increasing evidence of a link between Zika virus infection in 
pregnant women and adverse outcomes such as microcephaly
 Emerging information of an association between Zika virus infection and 
Guillain-Barré Syndrome, a rare neurological problem that can occur after 
an infection
DEFINING ZIKA VIRUS DISEASE
 Clinical Symptoms: One or more symptoms of acute onset fever, rash, joint 
pain, or conjunctivitis OR Guillain-Barré Syndrome
 A potential Zika virus exposure: 
– An individual who resided or traveled to an area with ongoing Zika 
virus transmission within two weeks of symptom onset
– Or a link to a person with laboratory evidence of recent Zika virus 
infection (for example, sexual partner or baby born to an infected 
mother) or an association in time and place with a confirmed case
 Laboratory evidence of Zika virus infection
DETECTING ZIKA VIRUS RNA AND ANTIBODIES
LABORATORY TESTING FOR ZIKA VIRUS IS ALSO CHALLENGING
 State, local, and territorial laboratories are critical for confirmation of Zika 
virus infection
 Clinicians should be educated to collect, store and transport the correct 
specimens for the available tests
 Laboratories should be supported to enhance surge capacity
– Plan for how to prioritize pregnant women for testing
– Supplies, equipment, staff, information technology support
– Laboratorian cross-training
– Communication planning
TESTING FOR ZIKA INFECTION IS A BALANCE
IDENTIFYING AND DIAGNOSING ZIKA IS IMPORTANT
 For clinical care: 
– To guide management of pregnant women with Zika infection
– To monitor certain outcomes in people with Zika infection 
 For public health action:
– Reduce opportunities for local transmission in states with known Aedes
aegypti and Aedes albopictus mosquitoes 
• Recommend infected people avoid exposure to the local mosquito 
populations
– Detect local transmission early to control spread
RECOGNIZING AND RESPONDING TO ZIKA VIRUS INFECTIONS
SURVEILLANCE
 Jurisdictions most likely to have Aedes aegypti and Aedes albopictus
mosquitoes should plan and implement surveillance activities to identify 
local transmission early
 Approaches to surveillance may include: 
– Enhance surveillance activities to identify potential additional cases 
near a travel-associated case
– Testing people with symptoms of Zika virus in areas with Aedes aegypti
and Aedes albopictus and known travel-associated cases
– Identifying unusual clusters of rash illness and testing for Zika
WHAT CDC IS DOING
 Providing guidance on who should be tested for Zika virus disease
 Providing guidance for surveillance before and during mosquito season
 Providing guidance on how to prevent transmission of Zika virus and 
rapidly identify cases
 CDC has developed and is distributing MAC-ELISA testing kits to states
 CDC has developed Trioplex rRT-PCR that detects Zika, dengue, and 
chikungunya virus RNA
WHAT YOUR ORGANIZATION CAN DO
 Surveillance provides data needed for action to prevent and control the 
spread of Zika virus
 Activities key to detecting transmission of Zika virus include
– Educate healthcare providers on how to identify cases of possible Zika 
virus infection and when to test
– Coordinate and support state and local laboratory testing
– Support local health departments to do surveillance and communicate 
to the public about how to reduce the risk of Zika transmission
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PREVENTING AND RESPONDING TO
MOSQUITO-BORNE ILLNESS
Lyle Petersen, MD, MPH
Director
Division of Vector-Borne Diseases
Incident Manager for Zika Response
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ESTIMATED RANGE OF AEDES AEGYPTI AND AEDES ALBOPICTUS
MOSQUITOES IN THE UNITED STATES
Aedes aegypti
*Maps have been updated from a variety of sources.  These maps represent CDC’s best estimate of the potential range of Aedes aegypti







 Lays eggs in standing water with a lot of 
organic material (lakes, ditches, gutters, 
neglected pools)
 CDC gravid and light traps for 
surveillance
Aedes aegypti/Ae. albopictus
 Mostly bite during the day, but can also bite at 
night
 Ae. aegypti prefers  to feed on people
 Ae. albopictus will feed on people and animals
 Prefers to lay eggs in man made containers 
that may dry out completely
 BG Sentinel traps and ovicups for surveillance
THE PURPOSE OF MOSQUITO CONTROL VARIES
Nuisance biting versus disease vectors
COUNTIES WITH REPORTED VECTOR CONTROL DISTRICTS
MOSQUITO CONTROL IN THE UNITED STATES
 Coordinated and funded locally in most areas
– Divided into mosquito control or abatement districts
 Many mosquito control programs are stand-alone divisions of local 
governments
– Need to link mosquito control districts with both state and local health 
departments
 State and local jurisdictions may have different laws and ordinances 
concerning mosquito control
– Stand-alone program or connected to health departments
– Especially relevant concerning property access
WHO IS RESPONSIBLE FOR MOSQUITO CONTROL?
 State boards/commissions/departments
 Tribal nations
 County mosquito boards (independent taxing districts)
 Local departments of health/environment
 Individual cities/townships
 Neighborhood associations
 Pest management professionals
WHO DOES MOSQUITO CONTROL?
 Local government programs – the 
community that needs abatement does all of 
the work
 Private contractors – an outside group is 
hired to perform abatement work
 Combination – a local government program 
exists, but some functions are contracted out  
– Aerial spraying is an example of a service that is 
commonly contracted by local governments
AEDES AEGYPTI AND AEDES ALBOPICTUS CONTROL
Focus at individual property level
 Targeted outdoor residual spraying
 Targeted indoor residual spraying when appropriate
 Larvicide in containers, tires, tree holes
 Sanitation
 Widespread space spraying when required 
WEST NILE VIRUS MOSQUITO (CULEX) CONTROL
Focus is on community level
 Widespread space spraying
 Larvicide in storm drains and septic ditches/tanks
 Fish or larvicides in abandoned pools 
 Larvicide in containers around homes 
WHAT YOU CAN DO BEFORE MOSQUITO SEASON
 Gather and review historical data and maps on the presence of vector 
mosquitoes
– If outdated, plan new surveys and assessments
 Develop a mosquito control strategy
 Develop a communications network through your jurisdictional incident 
management structure
 Engage communities about mosquito control plans and policies
 Identify staffing capacity, resource allocation, and technical expertise
WHAT YOU CAN DO DURING MOSQUITO SEASON
 Implement all mosquito control strategies, including:
– Immature mosquito monitoring
– Adult mosquito monitoring
– Remove or dump water sources where larvae can grow
– Use larvicides in water sources that cannot be removed or dumped
– Conduct insecticide resistance testing
 Actively engage communities to perform source reduction
WHAT YOU CAN DO IF ZIKA CASES ARE IDENTIFIED
 Mobilize comprehensive mosquito control strategies without delay
 Implement targeted vector control for adult and immature mosquitoes in 
and within 150 yards around an individual’s location
 Intensify larval control and source-reduction efforts
 Consider adding community-based adult mosquito control
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CALL TO ACTION: WHAT CAN STATE AND LOCAL LEADERS DO? 
Dr. Tom Frieden, MD, MPH
Director, Centers for Disease Control and Prevention
Considerations for Zika Action Planning
 Appoint an empowered Zika coordinator for 
your state
 Review preparedness plans
 Coordinate at state and local level






– Pregnant women outreach
– Blood safety
Some Challenges of Zika
 Planning and coordinating mosquito control throughout US
 Mosquito control in communities that are hesitant and/or lack abatement 
districts
 Coordinating mosquito control and services for women between tribal and 
state jurisdictions
 Aligning state Zika planning with community clinical services for 
reproductive-age and pregnant women
 Engaging providers and preparing social services for a possible rise in cases 
of microcephaly and Guillain-Barré
 Addressing blood safety concerns in areas with local transmission
Zika Requires an Urgent and Coordinated Response
 In US – varied risk, varied capacities, & varied 
response
 To tackle this problem we need to
– Collaborate across all levels of 
government and society
– Build sustainable epidemiologic, lab, and 
mosquito control capacity
 Our biggest challenges are speed and scale
– Mosquito populations double in days or 
weeks
– Can our response keep pace?
